Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
EV/Core EBITDA

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
   EV/Core EBITDA(x) 7.186.7912.651.601.54

What is the latest EV/Core EBITDA ratio of NATH BIOGENES (INDIA) ?

The latest EV/Core EBITDA ratio of NATH BIOGENES (INDIA) is 7.18 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20247.18
Mar20236.79
Mar202212.65
Mar20131.60
Mar20121.54

How is EV/Core EBITDA of NATH BIOGENES (INDIA) Trending?

Years EV/Core EBITDA % Change
Mar2024 7.18
5.74
Mar2023 6.79
-46.32
Mar2022 12.65
690.63
Mar2013 1.6
3.90
Mar2012 1.54 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare EV/Core EBITDA ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹375.3 Cr -2.4% 5.6% -1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,113.6 Cr -5.8% -6.3% 14.7% Stock Analytics
KAVERI SEED COMPANY ₹6,403.9 Cr -5.7% -15.3% 32.9% Stock Analytics
VENKYS (INDIA) ₹2,255.7 Cr -1.5% 0.4% -16.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,418.8 Cr -2% -1.8% -33.7% Stock Analytics
INDO US BIOTECH ₹303.6 Cr 1.5% 1.6% -27% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.4%

5.6%

-1%

SENSEX

0.1%

1.2%

6%


You may also like the below Video Courses